MINAPHARM Pharmaceuticals (EGX:MIPH)

MINAPHARM Pharmaceuticals Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,732	2,885	1,918	1,694	981.94	1,024
Short-Term Investments	5	5	-	-	-	-
Cash & Short-Term Investments	2,737	2,890	1,918	1,694	981.94	1,024
Cash Growth	-17.15%	50.70%	13.25%	72.47%	-4.06%	33.96%
Accounts Receivable	774.06	647.52	492.9	478.14	388.76	331.91
Other Receivables	98.41	76.37	46.13	12.22	5.52	5.67
Receivables	1,035	1,005	742.76	575.06	399.59	358.93
Inventory	1,297	1,233	1,055	838.28	668.51	587.16
Prepaid Expenses	44.47	30.33	10.76	12.41	6.54	5.89
Other Current Assets	402.62	558.59	315.92	524.8	345.77	205.54
Total Current Assets	5,516	5,717	4,042	3,644	2,402	2,181
Property, Plant & Equipment	5,909	5,687	4,251	2,685	1,340	1,004
Long-Term Investments	-	-	5	5	5	5
Goodwill	339.97	339.97	334.51	280.08	220.53	230.21
Other Intangible Assets	254.08	254.84	67.1	56.9	48.2	62.16
Long-Term Deferred Tax Assets	-	-	-	-	-	0.81
Other Long-Term Assets	287.55	4.92	3.22	134.67	89.77	-
Total Assets	12,307	12,003	8,704	6,806	4,106	3,483
Accounts Payable	1,189	1,189	735.34	677.29	416.64	508.39
Accrued Expenses	55.19	47.34	46.81	39.23	31.53	26.18
Short-Term Debt	2,076	2,191	2,043	1,042	542.29	747.41
Current Portion of Long-Term Debt	402.3	398.09	218.67	225.33	32.93	23.24
Current Portion of Leases	64.73	55.35	27.77	15.1	68.13	-
Current Income Taxes Payable	157.82	195.94	134.82	233.36	183.69	151.54
Current Unearned Revenue	15.65	14.62	9.81	7.45	5.04	4.44
Other Current Liabilities	596.84	495.28	314.7	261.3	208.89	168.76
Total Current Liabilities	4,557	4,587	3,531	2,501	1,489	1,630
Long-Term Debt	2,400	2,250	1,335	1,036	603.87	187.84
Long-Term Leases	563.99	562.68	153.62	114.83	1.17	-
Long-Term Deferred Tax Liabilities	46.68	27.54	44.99	56.01	22.69	18.53
Other Long-Term Liabilities	170.78	167.5	121.15	57.52	45.73	53.43
Total Liabilities	7,739	7,594	5,186	3,765	2,163	1,890
Common Stock	117.81	117.81	122.93	122.93	122.93	122.93
Retained Earnings	2,051	2,053	2,147	2,023	1,466	1,047
Treasury Stock	-	-	-69.63	-69.63	-	-
Comprehensive Income & Other	2,292	2,135	1,222	882.83	293.27	367.67
Total Common Equity	4,461	4,306	3,423	2,959	1,882	1,537
Minority Interest	107.44	102.74	94.61	81.82	61.29	56.04
Shareholders' Equity	4,568	4,409	3,517	3,041	1,943	1,593
Total Liabilities & Equity	12,307	12,003	8,704	6,806	4,106	3,483
Total Debt	5,507	5,457	3,779	2,433	1,248	958.49
Net Cash (Debt)	-2,770	-2,566	-1,861	-739.64	-266.46	65.01
Net Cash Per Share	-250.34	-231.95	-168.18	-64.46	-21.67	5.29
Filing Date Shares Outstanding	11.78	11.78	11.06	11.06	12.29	12.29
Total Common Shares Outstanding	11.78	11.78	11.06	11.06	12.29	12.29
Working Capital	959.02	1,130	511.26	1,143	913.2	551.05
Book Value Per Share	378.65	365.53	309.35	267.42	153.07	125.04
Tangible Book Value	3,867	3,711	3,021	2,622	1,613	1,245
Tangible Book Value Per Share	328.23	315.04	273.05	236.96	131.21	101.26
Land	58.25	55.2	39.7	33.23	26.15	27.3
Buildings	1,623	1,579	508.65	411.79	296.6	307.09
Machinery	2,680	2,505	1,777	1,365	977.94	961.26
Construction In Progress	311.31	2,988	2,936	1,666	666.97	357.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.